TG Therapeutics Inc. sell The Goldman Sachs Group, Inc.
Start price
24.07.23
/
50%
€18.25
Target price
24.07.24
€14.44
Performance (%)
-1.86%
End price
25.07.24
€17.91
Summary
This prediction ended on 25.07.24 with a price of €17.91. With a performance of -1.86%, the SELL prediction by The_Goldman_Sachs_Gr was trending in the right direction. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| TG Therapeutics Inc. | 2.923% | 2.923% | 58.776% | 170.508% |
| iShares Core DAX® | 0.855% | 0.389% | 2.533% | 52.003% |
| iShares Nasdaq 100 | -0.989% | -4.400% | 25.154% | 77.536% |
| iShares Nikkei 225® | -1.781% | -11.216% | 44.398% | 64.676% |
| iShares S&P 500 | 0.057% | 0.778% | 20.953% | 63.009% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread TG Therapeutics Inc. diskutieren
TG Therapeutics, Inc. (NASDAQ: TGTX) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $10.00 to $16.00. They now have a "sell" rating on the stock.
Ratings data for TGTX provided by MarketBeat
In the thread Trading TG Therapeutics Inc.
Die von The_Goldman_Sachs_Gr gewählte maximale Laufzeit wurde überschritten